Therapix Biosciences Ltd. is a specialty clinical-stage pharmaceutical company, focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. It initiated two internal drug development programs based on repurposing an FDA approved synthetic cannabinoid (dronabinol): Joint Pharma developing THX-TS01 targeted to the treatment of TS and BrainBright Pharma developing THX-ULD01 targeted to the high value and under-served market of MCIs. The company was founded on August 23, 2004 and is headquartered in Givatayim, Israel.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
11
Frequently Asked Questions
What is Market Cap of Therapix Biosciences Ltd - ADR?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Therapix Biosciences Ltd - ADR market cap is $2.32M.
What is the 52-week high for Therapix Biosciences Ltd - ADR?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Therapix Biosciences Ltd - ADR 52 week high is $3.24 as of October 10, 2025.
What is the 52-week low for Therapix Biosciences Ltd - ADR?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Therapix Biosciences Ltd - ADR 52 week low is $0.051 as of October 10, 2025.
What was Therapix Biosciences Ltd - ADR stock price yesterday?
Therapix Biosciences Ltd - ADR stock price yesterday was $0.1649.
What is the PE ratio of Therapix Biosciences Ltd - ADR?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Therapix Biosciences Ltd - ADR’s P/E ratio is None.
What is the Price-to-Book ratio of Therapix Biosciences Ltd - ADR?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Therapix Biosciences Ltd - ADR P/B ratio is 3.1255.
What is Therapix Biosciences Ltd - ADR's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Therapix Biosciences Ltd - ADR's EBITDA is N/A.
What is the 50-day moving average of Therapix Biosciences Ltd - ADR?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Therapix Biosciences Ltd - ADR 50-day moving average is $0.325.
How many employess does Therapix Biosciences Ltd - ADR has?